Table 1 Effect of metronidazole vaginal tablet

Age (years old)

47.9 ± 7.7 (35–81)

47.3 ± 5.4 (54–73)

NS

BMI (kg/m²)

23.0 ± 3.6 (15.9–37.8)

22.9 ± 3.9 (15.1–46.5)

NS

Nulliparity

n 28/95

n 168/425

NS

Gynecological operation history

n 20/95

n 88/425

NS

Menstrual disorder

n 76/95

n 330/425

NS

Abdominal distension

n 13/95

n 119/425

 < 0.01

GnRH analog

n 47/95

n 306/425

 < 0.01

Concomitant LC

n 6/95

n 23/425

NS

Concomitant PLA

n 6/95

n 20/425

NS

Operation time (minutes)

198.2 ± 53.1 (94–361)

206.0 ± 56.2 (99–504)

NS

Blood loss (mL)

135.7 ± 185.6 (0–1189)

121.6 ± 200.9 (0–2003)

NS

Uterine weight (g)

257.5 ± 155.8 (50–925.2)

324.4 ± 234.7 (28–1454)

< 0.05

Abdominal adhesion

n 35/95

n 182/425

NS

Blood transfusion

n 5/95

n 19/425

NS

Leiomyoma size (cm)

5.7 ± 2.4 (1.7–12.5)

6.5 ± 3.1 (1.1–20.0)

< 0.05

Uterine size (cm)

7.0 ± 1.7 (2.9–11.9)

7.4 ± 2.0 (3.0–15.5)

NS

VBRPC

n 6/95

n 10/425

< 0.05